AKTS CIK: 2035832

Aktis Oncology, Inc.

  • United States
  • Technology
Metrics score locked — part of Premium
FY23
FY23
FY24
FY24
FY25
FY23 – FY25
(positive)
Change from FY23 to FY24
millions USD
FY23:
−3.12
FY23:
–
FY24:
−0.69
FY24:
–
FY25:
–
(positive)
Change from FY23 to FY25
millions USD
FY23:
−66.1
FY23:
−34.8
FY24:
−66.6
FY24:
−52.1
FY25:
−74.7
(positive)
Change from FY23 to FY25
millions USD
FY23:
−53.0
FY23:
−34.4
FY24:
−53.4
FY24:
−50.5
FY25:
−72.4
(positive)
Change from FY23 to FY25
millions USD
FY23:
−66.0
FY23:
−28.6
FY24:
−168
FY24:
−44.0
FY25:
−63.7
(positive)
Change from FY23 to FY25
millions USD
FY23:
−63.6
FY23:
−28.6
FY24:
−168
FY24:
−44.0
FY25:
−63.7

All amounts in millions USD Data source:Twelve Data